Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-demecolcine | decreases expression | ISO | CNOT6L (Homo sapiens) | 6480464 | Demecolcine results in decreased expression of CNOT6L mRNA | CTD | PMID:23649840 | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | CNOT6L (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CNOT6L mRNA | CTD | PMID:22079256 | 1,2-dimethylhydrazine | decreases expression | ISO | Cnot6l (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of CNOT6L mRNA | CTD | PMID:22206623 | 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of CNOT6L mRNA | CTD | PMID:29097150 | 2,3',4,4',5-Pentachlorobiphenyl | increases expression | ISO | Cnot6l (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:31388691 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Cnot6l (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of CNOT6L mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CNOT6L mRNA | CTD | PMID:33387578 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CNOT6L mRNA | CTD | PMID:32109520 | 2,3,7,8-Tetrachlorodibenzofuran | decreases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:32109520 | 2-butoxyethanol | decreases expression | ISO | Cnot6l (Mus musculus) | 6480464 | n-butoxyethanol results in decreased expression of CNOT6L mRNA | CTD | PMID:19812364 | 3,4-methylenedioxymethamphetamine | increases expression | EXP | | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of CNOT6L mRNA | CTD | PMID:30071829 | 4,4'-diaminodiphenylmethane | decreases expression | ISO | Cnot6l (Mus musculus) | 6480464 | 4 and 4'-diaminodiphenylmethane results in decreased expression of CNOT6L mRNA | CTD | PMID:18648102 | acetamide | decreases expression | EXP | | 6480464 | acetamide results in decreased expression of CNOT6L mRNA | CTD | PMID:31881176 | acrylamide | increases expression | ISO | CNOT6L (Homo sapiens) | 6480464 | Acrylamide results in increased expression of CNOT6L mRNA | CTD | PMID:32763439 | aristolochic acid A | decreases expression | ISO | CNOT6L (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of CNOT6L mRNA | CTD | PMID:33212167 | arsenous acid | increases expression | ISO | CNOT6L (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of CNOT6L mRNA | CTD | PMID:20458559 | benzo[a]pyrene | decreases expression | ISO | Cnot6l (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of CNOT6L mRNA | CTD | PMID:19770486 | benzo[a]pyrene diol epoxide I | decreases expression | ISO | CNOT6L (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:19150397 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of CNOT6L mRNA | CTD | PMID:25181051 | bisphenol A | decreases expression | ISO | CNOT6L (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of CNOT6L protein | CTD | PMID:31675489 | bisphenol A | multiple interactions | ISO | CNOT6L (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of CNOT6L gene | CTD | PMID:31601247 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of CNOT6L mRNA | CTD | PMID:33296240 | butanal | decreases expression | ISO | CNOT6L (Homo sapiens) | 6480464 | butyraldehyde results in decreased expression of CNOT6L mRNA | CTD | PMID:26079696 | cadmium atom | multiple interactions | ISO | CNOT6L (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CNOT6L mRNA | CTD | PMID:35301059 | cadmium dichloride | multiple interactions | ISO | CNOT6L (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CNOT6L mRNA | CTD | PMID:35301059 | cyclosporin A | decreases expression | ISO | CNOT6L (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of CNOT6L mRNA | CTD | PMID:25562108 | decabromodiphenyl ether | decreases expression | ISO | CNOT6L (Homo sapiens) | 6480464 | decabromobiphenyl ether results in decreased expression of CNOT6L protein | CTD | PMID:31675489 | diarsenic trioxide | increases expression | ISO | CNOT6L (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of CNOT6L mRNA | CTD | PMID:20458559 | dibenzo[a,l]pyrene | increases expression | ISO | Cnot6l (Mus musculus) | 6480464 | dibenzo(a and l)pyrene results in increased expression of CNOT6L mRNA | CTD | PMID:25908611 | dorsomorphin | multiple interactions | ISO | CNOT6L (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | formaldehyde | decreases expression | ISO | CNOT6L (Homo sapiens) | 6480464 | Formaldehyde results in decreased expression of CNOT6L mRNA | CTD | PMID:23649840 | fulvestrant | multiple interactions | ISO | CNOT6L (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of CNOT6L gene | CTD | PMID:31601247 | gallic acid | decreases expression | ISO | CNOT6L (Homo sapiens) | 6480464 | Gallic Acid results in decreased expression of CNOT6L mRNA | CTD | PMID:34408198 | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of CNOT6L mRNA | CTD | PMID:22061828 and PMID:33387578 | manganese atom | increases expression | ISO | CNOT6L (Homo sapiens) | 6480464 | Manganese results in increased expression of CNOT6L mRNA | CTD | PMID:17175027 | manganese(0) | increases expression | ISO | CNOT6L (Homo sapiens) | 6480464 | Manganese results in increased expression of CNOT6L mRNA | CTD | PMID:17175027 | manganese(II) chloride | increases expression | ISO | CNOT6L (Homo sapiens) | 6480464 | manganese chloride results in increased expression of CNOT6L mRNA | CTD | PMID:17175027 | methamphetamine | increases expression | EXP | | 6480464 | Methamphetamine results in increased expression of CNOT6L mRNA | CTD | PMID:19564919 | methamphetamine | multiple interactions | EXP | | 6480464 | [Methamphetamine co-treated with SCH 23390] results in increased expression of CNOT6L mRNA | CTD | PMID:19564919 | methapyrilene | decreases expression | EXP | | 6480464 | Methapyrilene results in decreased expression of CNOT6L mRNA | CTD | PMID:30467583 | methyl methanesulfonate | increases expression | ISO | CNOT6L (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in increased expression of CNOT6L mRNA | CTD | PMID:23649840 | methylmercury chloride | decreases expression | ISO | CNOT6L (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of CNOT6L mRNA | CTD | PMID:28001369 | methylphenidate | decreases expression | ISO | Cnot6l (Mus musculus) | 6480464 | Methylphenidate results in decreased expression of CNOT6L mRNA | CTD | PMID:22470460 | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of CNOT6L mRNA | CTD | PMID:25729387 | paracetamol | increases expression | ISO | CNOT6L (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of CNOT6L mRNA | CTD | PMID:26690555 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of CNOT6L mRNA | CTD | PMID:33387578 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Cnot6l (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of CNOT6L mRNA | CTD | PMID:36331819 | phenobarbital | affects expression | ISO | Cnot6l (Mus musculus) | 6480464 | Phenobarbital affects the expression of CNOT6L mRNA | CTD | PMID:23091169 | pirinixic acid | increases expression | ISO | Cnot6l (Mus musculus) | 6480464 | pirinixic acid results in increased expression of CNOT6L mRNA | CTD | PMID:17426115 and PMID:23811191 | potassium chromate | decreases expression | ISO | CNOT6L (Homo sapiens) | 6480464 | potassium chromate(VI) results in decreased expression of CNOT6L mRNA | CTD | PMID:22079256 | potassium chromate | multiple interactions | ISO | CNOT6L (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CNOT6L mRNA | CTD | PMID:22079256 | SB 431542 | multiple interactions | ISO | CNOT6L (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | SCH 23390 | multiple interactions | EXP | | 6480464 | [Methamphetamine co-treated with SCH 23390] results in increased expression of CNOT6L mRNA | CTD | PMID:19564919 | SCH 23390 | increases expression | EXP | | 6480464 | SCH 23390 results in increased expression of CNOT6L mRNA | CTD | PMID:19564919 | silver atom | decreases expression | ISO | Cnot6l (Mus musculus) | 6480464 | Silver results in decreased expression of CNOT6L mRNA | CTD | PMID:27131904 | silver(0) | decreases expression | ISO | Cnot6l (Mus musculus) | 6480464 | Silver results in decreased expression of CNOT6L mRNA | CTD | PMID:27131904 | sodium arsenate | increases expression | ISO | Cnot6l (Mus musculus) | 6480464 | sodium arsenate results in increased expression of CNOT6L mRNA | CTD | PMID:30953684 | sodium fluoride | decreases expression | ISO | Cnot6l (Mus musculus) | 6480464 | Sodium Fluoride results in decreased expression of CNOT6L mRNA | CTD | PMID:27862939 | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of CNOT6L mRNA | CTD | PMID:34492290 | topotecan | decreases expression | EXP | | 6480464 | Topotecan results in decreased expression of CNOT6L mRNA | CTD | PMID:25729387 | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of CNOT6L mRNA | CTD | PMID:25729387 | torcetrapib | increases expression | ISO | CNOT6L (Homo sapiens) | 6480464 | torcetrapib results in increased expression of CNOT6L mRNA | CTD | PMID:23228038 | trichostatin A | increases expression | ISO | CNOT6L (Homo sapiens) | 6480464 | trichostatin A results in increased expression of CNOT6L mRNA | CTD | PMID:24935251 and PMID:26272509 | trichostatin A | multiple interactions | ISO | CNOT6L (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CNOT6L mRNA | CTD | PMID:27188386 | troglitazone | decreases expression | ISO | Cnot6l (Mus musculus) | 6480464 | troglitazone results in decreased expression of CNOT6L mRNA | CTD | PMID:28973697 | valproic acid | decreases expression | ISO | CNOT6L (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of CNOT6L mRNA | CTD | PMID:23179753 and PMID:28001369 | valproic acid | affects expression | ISO | CNOT6L (Homo sapiens) | 6480464 | Valproic Acid affects the expression of CNOT6L mRNA | CTD | PMID:25979313 | valproic acid | increases expression | ISO | CNOT6L (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of CNOT6L mRNA | CTD | PMID:26272509 | valproic acid | multiple interactions | ISO | CNOT6L (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CNOT6L mRNA | CTD | PMID:27188386 | vincristine | decreases expression | ISO | CNOT6L (Homo sapiens) | 6480464 | Vincristine results in decreased expression of CNOT6L mRNA | CTD | PMID:23649840 | |